St Pharm Co., Ltd.

Uk-Il Kim

Kyungjin Kim

Bong Jin Kim

Ill Young Lee

Chong-Kyo Lee

Jong Chan Son

Jae Hak Kim

Ji Hye Yoon

Hyung Tae Bang

Yejin Jang

Hong Suk Shin

Hwa Jung Nam

Meehyein Kim

Yun Young Go

Hwajung Nam

Jihye Yoon

Jin Soo Shin

The present disclosure relates to a novel nucleoside or nucleotide derivative, a racemate thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating viral infection-associated diseases, containing the same as an active ingredient.

Nucleoside or nucleotide derivatives, and uses thereof

Provided is a novel pyrrolopyridine compound represented by Chemical Formula I, a racemate or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof; and to a method for preparing the same. A compound represented by Chemical Formula I shows high selectivity and antiviral activity against human immunodeficiency virus (HIV), with low toxicity; therefore, it is useful as a therapeutic agent for viral infection, in particular, HIV infection.

Pyrrolopyridine derivative, method for producing same, and use thereof

The present invention relates to a novel dihydropyranopyrimidinone derivative, a tautomer thereof, a stereoisomer thereof and their mixture, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating a tankyrase-related disease, which contains the same as an active ingredient.

Dihydropyranopyrimidinone derivatives, and use thereof

Growing community of inventors

Siheung-si, South Korea

Uk-Il Kim